A growing arsenal of new drugs that unleash the body’s immune system against tumors has captured the cancer treatment spotlight.
Radioimmunotherapy is a combination of radiation therapy and immunotherapy.
In gynecologic cancers, immunotherapy is being used in all stages of treatment, and researchers are trying to enhance the effects of different immunotherapy approaches.
Researchers are confident that the potential of checkpoint inhibitors has only begun to be tapped.
Immunotherapy can be dramatically successful for people with limited options — so scientists are working on expanding the benefits to other patients.
Researchers are applying the knowledge they’ve gained in previous clinical trials as they look into how immunotherapy might provide additional treatment options for patients with recurrent cervical cancer.
Immunotherapy is a kind of treatment that has had stunning results in some patients with cancers like melanoma, lymphoma, and kidney cancer. Immunotherapy drugs empower the body’s immune system by enabling the body to fight cancer — an approach that can slow or halt cancer in certain patients. In our […]
Precision medicine and immunotherapy are changing the landscape of cancer treatment. The aim of precision medicine, sometimes called personalized medicine, is to match treatments to individual patients taking into account their genetic makeup, medical history, test results, and other distinctive characteristics. Unlike precision medicine, immunotherapy is a particular form of treatment, […]
It’s not uncommon for cancer patients to take to a pen after a diagnosis. Peter Rooney’s taken that to another level. Rooney, a former journalist and author of the book Die Free, captured his cancer journey in the new book Immunopatient: The New Frontier of Curing Cancer. The following excerpt […]
The approval of a targeted therapy and an immunotherapy drug for some patients with advanced stomach cancer reflects recent new approaches to this difficult-to-treat cancer that hasn’t had many therapeutic advances in recent years. Stomach cancer, uncommon in the United States but a leading cause of cancer death globally, causes […]
Small cell lung cancer is the most aggressive type of lung cancer. Unlike its far more common counterpart, non-small cell lung cancer, treatment with immunotherapy drugs hasn’t yet been approved for small cell lung cancer, but some early findings in clinical trials suggest this type of treatment may have potential. […]
This originally appeared on Vector, Boston Children’s Hospital’s blog. A novel screening method using CRISPR-Cas9 genome editing technology has revealed new drug targets that could potentially enhance the effectiveness of PD-1 checkpoint inhibitors, a promising new class of cancer immunotherapy. The method, developed by a team at Dana-Farber/Boston Children’s Cancer and […]
Immunotherapy refers to treatments that use the body’s own immune system to combat diseases. While no immunotherapy drugs are currently approved for breast cancer, clinical trials at Dana-Farber and elsewhere are exploring the effectiveness of these drugs — and whether they could work in combination with other cancer therapies. “I […]
Vaccines, drugs, and modified human cells that activate the immune system against cancer have improved outcomes and prolonged lives in some types of cancer in the past few years. For patients with glioblastoma, the most common primary brain tumor in adults, immunotherapy has shown some promise in clinical trials — […]
Prostate cancer can be treated by immunotherapy, and it was the first form of cancer for which a vaccine therapy – a treatment that stimulates the immune system to attack a disease – was approved by the U.S. Food and Drug Administration (FDA). That vaccine, called Provenge, was cleared by the […]
While new types of immunotherapy are being used to treat a wide variety of cancers, immunotherapy has been a front-line treatment for lymphoma for decades. Lymphoma occurs when white blood cells known as lymphocytes grow abnormally. There are nearly 70 subtypes of Hodgkin lymphoma and non-Hodgkin lymphoma that have been […]
Immunotherapy has revolutionized the treatment of many types of cancer and is now undergoing testing in ovarian cancer. Clinical trials of drugs known as immune checkpoint inhibitors, which can unleash a potent immune system attack on cancer cells, have produced remissions in about 10-15 percent of patients with advanced and […]
It’s a compelling idea that has attracted scientists for decades: rather than poison tumors with chemicals and radiation, use a biological agent – a vaccine – to rally the body’s formidable immune defenders to kill cancer cells and shrink tumors. Yet, even as other forms of immunotherapy are showing promise […]
Cancers of the colon and rectum haven’t yet been as effectively treated with immunotherapy as have melanoma and lung cancer, but researchers are increasingly identifying patients who do appear to benefit from the immunity-boosting drugs – and devising strategies they hope will expand the reach of immunotherapy in colorectal cancers. […]
There has been much excitement in recent years around new drugs that exploit the power of the body’s immune system to fight cancer. In some patients, even with advanced cancers, these immunotherapy treatments have slowed or halted the disease after standard treatments no longer worked, with remissions lasting several years […]